Learning Objectives:

1.  Review the eveidence supporting the link between thegut microbiota and its effect on anti-cancer treatment.

2.  Highlight novel strategies to modulate the gut microbiome to optimize efficacy of PD-1 based immunotherapy

3. Discuss potential clinical studies to assess safety and feasibility of gut mirobiome interventions

Session date: 
Monday, February 8, 2021 - 12:00pm to 1:00pm
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Carolina Soto Chervin, MD, PhD